Background Several inflammation-based scoring systems and nutritional indicators have
been shown to have relevance to survival of patients with non-small cell lung cancer …

Clinical and pathological predictors have proved to be insufficient in identifying high-risk
patients who develop cancer recurrence after tumour resection. We aimed to compare the …

Background Inflammation in the tumor microenvironment is hypothesized to have a major
role in cancer invasiveness, progression, and metastases. The purpose of this study was to …

Background Inflammation-based prognostic scores, including Glasgow prognostic score
(GPS), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic …

Introduction The preoperative inflammatory and nutrient status of the patient are closely
correlated to the outcome of surgery-based treatment for non-small cell lung cancer …

Background Emerging inflammatory response biomarkers are developed to predict the
survival of patients with cancer, the aim of our study is to establish an inflammation-related …

Objective To investigate the prognostic significance of the advanced lung cancer
inflammation index (ALI) in patients with operable non-small-cell lung carcinoma (NSCLC) …

Background Several previous researchers have investigated the prognostic value of the
combinations of systemic inflammatory markers. However, the prognostic power of these …

Purpose: The correlation of advanced cancer with inflammation and/or nutrition factors is
well known. Recently, the advanced lung cancer inflammation index (ALI) was developed as …

Inflammatory biomarkers have been associated with clinical outcomes in non-small cell lung
cancer (NSCLC). However, the best prognostic marker (s) has not been identified, and the …